Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

1.

Bevacizumab with FOLFIRI or XELIRI in the First-line Therapy of Metastatic Colorectal Carcinoma: Results from Czech Observational Registry.

Kocakova I, Melichar B, Kocak I, Bortlicek Z, Büchler T, Dusek L, Petruzelka L, Kohoutek M, Prausová J, Finek J, Mohelnikova-Duchonova B, Vyzula R.

Anticancer Res. 2015 Jun;35(6):3455-61.

PMID:
26026110
2.

Evaluation of HER2 Gene Status in Breast Cancer Samples with Indeterminate Fluorescence in Situ Hybridization by Quantitative Real-Time PCR.

Koudelakova V, Berkovcova J, Trojanec R, Vrbkova J, Radova L, Ehrmann J, Kolar Z, Melichar B, Hajduch M.

J Mol Diagn. 2015 Jul;17(4):446-55. doi: 10.1016/j.jmoldx.2015.03.007. Epub 2015 May 5.

PMID:
25956448
3.

Comparison of Two Prognostic Models in Patients with Metastatic Renal Cancer Treated with Sunitinib: a Retrospective, Registry-Based Study.

Kubackova K, Melichar B, Bortlicek Z, Pavlik T, Poprach A, Svoboda M, Lakomy R, Vyzula R, Kiss I, Dusek L, Prausova J, Buchler T; Czech Renal Cancer Cooperative Group.

Target Oncol. 2015 Apr 23. [Epub ahead of print]

PMID:
25903462
4.

Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view.

Bencsikova B, Bortlicek Z, Halamkova J, Ostrizkova L, Kiss I, Melichar B, Pavlik T, Dusek L, Valik D, Vyzula R, Zdrazilova-Dubska L.

BMC Gastroenterol. 2015 Mar 24;15:37. doi: 10.1186/s12876-015-0266-6.

5.

Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study.

Melichar B, Adenis A, Lockhart AC, Bennouna J, Dees EC, Kayaleh O, Obermannova R, DeMichele A, Zatloukal P, Zhang B, Ullmann CD, Schusterbauer C.

Lancet Oncol. 2015 Apr;16(4):395-405. doi: 10.1016/S1470-2045(15)70051-3. Epub 2015 Feb 27.

PMID:
25728526
6.

The highs and lows of tumor biomarkers: lost illusions.

Melichar B.

Clin Chem Lab Med. 2015 Feb;53(3):343-7. doi: 10.1515/cclm-2015-0014. No abstract available.

PMID:
25720127
7.

Brain metastases of parathyroid carcinoma: Review of the literature and a case report.

Studentova H, Melichar B, Cincibuch J, Kaminek M, Frysak Z, Geierova M, Klein J.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Feb 10. doi: 10.5507/bp.2015.001. [Epub ahead of print]

8.

Efficacy of sunitinib in patients with metastatic or unresectable renal cell carcinoma and renal insufficiency.

Poprach A, Bortlicek Z, Melichar B, Lakomy R, Svoboda M, Kiss I, Zemanova M, Fiala O, Kubackova K, Coufal O, Pavlik T, Dusek L, Vyzula R, Buchler T.

Eur J Cancer. 2015 Mar;51(4):507-13. doi: 10.1016/j.ejca.2014.12.010. Epub 2015 Jan 7.

PMID:
25577735
9.

Hepatic arterial infusion in hepatocellular carcinoma: a single center experience.

Melichar B, Dvorak J, Ferko A, Kamaradova K, Krajina A.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Mar;159(1):139-44. doi: 10.5507/bp.2014.054. Epub 2014 Nov 11.

10.

Determination of lipidomic differences between human breast cancer and surrounding normal tissues using HILIC-HPLC/ESI-MS and multivariate data analysis.

Cífková E, Holčapek M, Lísa M, Vrána D, Gatěk J, Melichar B.

Anal Bioanal Chem. 2015 Jan;407(3):991-1002. doi: 10.1007/s00216-014-8272-z. Epub 2014 Oct 29.

PMID:
25352274
11.

Role of subcutaneous formulation of trastuzumab in the treatment of patients with HER2-positive breast cancer.

Melichar B, Študentová H, Kalábová H, Vitásková D.

Immunotherapy. 2014;6(7):811-9. doi: 10.2217/imt.14.50.

PMID:
25290414
12.

Prognostic significance of CD3+ tumor-infiltrating lymphocytes in patients with endometrial carcinoma.

Čermáková P, Melichar B, Tomšová M, Zoul Z, Kalábová H, Spaček J, Doležel M.

Anticancer Res. 2014 Oct;34(10):5555-61.

PMID:
25275055
13.

Oral ridaforolimus plus trastuzumab for patients with HER2+ trastuzumab-refractory metastatic breast cancer.

Seiler M, Ray-Coquard I, Melichar B, Yardley DA, Wang RX, Dodion PF, Lee MA.

Clin Breast Cancer. 2015 Feb;15(1):60-5. doi: 10.1016/j.clbc.2014.07.008. Epub 2014 Aug 17.

PMID:
25239224
14.

Urinary neopterin concentrations during combination therapy with cetuximab in previously treated patients with metastatic colorectal carcinoma.

Melichar B, Kalábová H, Krčmová LK, Trivedi SV, Králíčková P, Malířová E, Pecka M, Študentová H, Zezulová M, Holečková P, Solichová D.

In Vivo. 2014 Sep-Oct;28(5):953-9.

PMID:
25189913
15.

FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapy.

Mohelnikova-Duchonova B, Melichar B, Soucek P.

World J Gastroenterol. 2014 Aug 14;20(30):10316-30. doi: 10.3748/wjg.v20.i30.10316.

16.

Role of solute carrier transporters in pancreatic cancer: a review.

Lemstrová R, Souček P, Melichar B, Mohelnikova-Duchonova B.

Pharmacogenomics. 2014 Jun;15(8):1133-45. doi: 10.2217/pgs.14.80. Review.

PMID:
25084206
17.

Predictive parameters for internal mammary node drainage in patients with early breast cancer.

Lukesova L, Vrana D, Gatek J, Koranda P, Cwiertka K, Radova L, Melichar B, Prouzova Z, Sramek V, Svach I.

Tumori. 2014 May-Jun;100(3):254-8. doi: 10.1700/1578.17194.

PMID:
25076234
18.

Prevalence of perfusion defects detected by stress 99mtechnetium sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with breast cancer.

Melichar B, Doležal J, Srámek V, Kalábová H, Krčmová LK, Hyšpler R, Studentová H, Vošmik M, Pecka M, Svobodník A, Pecen L, Doležel M, Solichová D.

Anticancer Res. 2014 Jul;34(7):3689-94.

PMID:
24982388
19.

Intestinal permeability in patients with metastatic colon cancer treated with patupilone.

Melichar B, Hyšpler R, Tichá A, Kalábová H, Vitásková D, Zezulová M, Dvořák J, Cerman J Jr, Doležel M.

Clin Chem Lab Med. 2014 Nov;52(11):1649-55. doi: 10.1515/cclm-2014-0096.

PMID:
24937505
20.

Colorectal cancer and screening programs: not only analytical issues.

Plebani M, Lippi G, Melichar B.

Clin Chem Lab Med. 2014 Aug;52(8):1087-90. doi: 10.1515/cclm-2014-0508. No abstract available.

PMID:
24897408
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk